Kim H, Kang S, Yim H, Suh S, Jung Y, Kim J
Microorganisms. 2025; 13(2).
PMID: 40005585
PMC: 11857378.
DOI: 10.3390/microorganisms13020218.
Ishikawa T, Suzuki M, Honma T, Yoshida T
Transl Gastroenterol Hepatol. 2025; 10:5.
PMID: 39944583
PMC: 11811561.
DOI: 10.21037/tgh-24-103.
Cui K, Liu C, Teng X, Chen F, Xu Y, Zhou S
Infect Drug Resist. 2025; 18():113-126.
PMID: 39803304
PMC: 11721331.
DOI: 10.2147/IDR.S500291.
Georgakopoulou V
World J Virol. 2024; 13(4):98600.
PMID: 39722753
PMC: 11551690.
DOI: 10.5501/wjv.v13.i4.98600.
Louhab I, Daoudi H, Elcadi M, El Amin G, Zouaki A, Zirar J
Cureus. 2024; 16(11):e73550.
PMID: 39677079
PMC: 11638146.
DOI: 10.7759/cureus.73550.
Macrophage Evolution during Progression of Hepatitis Virus B-Related Acute-on-Chronic Liver Failure.
Rao J, Ye D, Ren A, He W, Zhang X, Chen P
J Innate Immun. 2024; 17(1):29-43.
PMID: 39637841
PMC: 11753795.
DOI: 10.1159/000542946.
Switching to Tenofovir Therapy Versus Continuation of Entecavir for Patients With Hepatitis B Virus Infection: A Systematic Review and Meta-Analysis.
Shahzil M, Chaudhary A, Kashif T, Qureshi A, Muhammad A, Khan F
JGH Open. 2024; 8(11):e70055.
PMID: 39588267
PMC: 11586466.
DOI: 10.1002/jgh3.70055.
The Efficacy of Post-Exposure Prophylaxis in Infants Born to HBsAg-Positive Mothers: A Single Center Experience in Saudi Arabia.
Al Qurashi M, Al-Najjar H, Aga S, Mohammad H, Mustafa A, Al Hindi M
Glob Pediatr Health. 2024; 11:2333794X241290780.
PMID: 39429536
PMC: 11490950.
DOI: 10.1177/2333794X241290780.
SEMA6B induces macrophage-mediated inflammation and hepatocyte apoptosis in hepatitis B virus-related acute-on-chronic liver failure.
Yang H, Cai Q, Xin J, Liang X, Hassan H, Chen J
Theranostics. 2024; 14(13):5200-5218.
PMID: 39267780
PMC: 11388073.
DOI: 10.7150/thno.97007.
High prevalence of hepatitis B and HIV among women survivors of sexual violence in South Kivu province, eastern Democratic Republic of Congo.
Basimane Bisimwa P, Koyaweda G, Bihehe Masemo D, Ayagirwe R, Birindwa A, Bisimwa P
PLoS One. 2024; 19(7):e0292473.
PMID: 38959256
PMC: 11221749.
DOI: 10.1371/journal.pone.0292473.
Five-year Treatment with Tenofovir Alafenamide Achieves High Rates of Viral Suppression, Alanine Aminotransferase Normalization, and Favorable Bone and Renal Safety in Chinese Chronic Hepatitis B Patients.
Hou J, Ning Q, Duan Z, Chen Y, Xie Q, Zhang L
J Clin Transl Hepatol. 2024; 12(5):469-480.
PMID: 38779514
PMC: 11106352.
DOI: 10.14218/JCTH.2023.00417.
Barriers to accessing hepatitis B medication: a qualitative study from the USA and Canada.
Jackson M, Ibrahim Y, Freeland C, Jacob S, Zovich B, Cohen C
BMJ Open. 2024; 14(5):e080658.
PMID: 38772585
PMC: 11110584.
DOI: 10.1136/bmjopen-2023-080658.
Clinical Applications of Quantitative Real-Time PCR in Virology.
Engstrom-Melnyk J, Rodriguez P, Peraud O, Hein R
Methods Microbiol. 2024; 42:161-197.
PMID: 38620180
PMC: 7148891.
DOI: 10.1016/bs.mim.2015.04.005.
Chronic hepatitis B and occult infection in chemotherapy patients - evaluation in oncology and hemato-oncology settings: The CHOICE study.
Sudevan N, Manrai M, Tilak T, Khurana H, Premdeep H
World J Virol. 2024; 13(1):89104.
PMID: 38616860
PMC: 11008399.
DOI: 10.5501/wjv.v13.i1.89104.
Antiviral Therapy of Chronic Hepatitis B Virus between Present and Future.
Ignat M, Balta A, Barbu R, Draganescu M, Nechita L, Voinescu D
J Clin Med. 2024; 13(7).
PMID: 38610820
PMC: 11012273.
DOI: 10.3390/jcm13072055.
Advances in discovery of novel investigational agents for functional cure of chronic hepatitis B: A comprehensive review of phases II and III therapeutic agents.
Lam R, Lim J
World J Hepatol. 2024; 16(3):331-343.
PMID: 38577537
PMC: 10989302.
DOI: 10.4254/wjh.v16.i3.331.
Plasma thrombomodulin as a candidate biomarker for the diagnosis and prognosis of HBV-related acute-on-chronic liver failure.
Zhou X, Luo J, Liang X, Li P, Ren K, Shi D
Infect Drug Resist. 2024; 17:1185-1198.
PMID: 38560706
PMC: 10981872.
DOI: 10.2147/IDR.S437926.
Alteration of serum bile acid profiles of HBV-related hepatocellular carcinoma identified by LC-MS/MS.
Dai S, Zhu J, Chen X, Zheng L, Li X, Liu L
J Cancer Res Clin Oncol. 2024; 150(3):157.
PMID: 38528272
PMC: 10963458.
DOI: 10.1007/s00432-024-05686-6.
Risk Factors for Development of Cirrhosis in Chronic Viral Hepatitis B Patients Who Had Persistent Viral Suppression With Antiviral Therapy.
Maung S, Decharatanachart P, Treeprasertsuk S, Chaiteerakij R
J Clin Exp Hepatol. 2024; 14(4):101388.
PMID: 38523735
PMC: 10956063.
DOI: 10.1016/j.jceh.2024.101388.
The 90-Day Survival Threshold: A Pivotal Determinant of Long-Term Prognosis in HBV-ACLF Patients - Insights from a Prospective Longitudinal Cohort Study.
Xiao L, Chen J, Zhao S, Zhoudi W, He K, Qian X
Adv Sci (Weinh). 2024; 11(16):e2304381.
PMID: 38380526
PMC: 11040353.
DOI: 10.1002/advs.202304381.
